Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC

Behavioural and functional characterization of Kv10.1 (Eag1) knockout mice

(2013) Roser Ufartes et al.   HUMAN MOLECULAR GENETICS

Current Therapeutic Strategy for Multiple Myeloma

(2013) Kenshi Suzuki   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Astemizole: an Old Anti-histamine as a New Promising Anti-cancer Drug

(2012) Janice Garcia-Quiroz et al.   Anti-Cancer Agents in Medicinal Chemistry

New Insight into P-Glycoprotein as a Drug Target

(2012) Albert Breier et al.   Anti-Cancer Agents in Medicinal Chemistry

Eag1 Channels as Potential Cancer Biomarkers

(2012) Jesús Adrián Rodríguez-Rasgado et al.   SENSORS

Functional KV10.1 Channels Localize to the Inner Nuclear Membrane

(2011) Ye Chen et al.   PLoS One

The Eag potassium channel as a new prognostic marker in ovarian cancer

(2010) Viren Asher et al.   Diagnostic Pathology

The potassium channel Ether a go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia

(2010) Jasmin R Agarwal et al.   Molecular Cancer

Estrogens and Human Papilloma Virus Oncogenes Regulate Human Ether-a-go-go-1 Potassium Channel Expression

(2009) L. Diaz et al.   CANCER RESEARCH

Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells

(2009) Rocío García-Becerra et al.   EXPERIMENTAL CELL RESEARCH

Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

(2009) Sean F. Altekruse et al.   JOURNAL OF CLINICAL ONCOLOGY

Voltage-gated potassium channels as therapeutic targets

(2009) Heike Wulff et al.   NATURE REVIEWS DRUG DISCOVERY

Eag1: An Emerging Oncological Target

(2008) L. A. Pardo et al.   CANCER RESEARCH

Eag1 Expression Interferes with Hypoxia Homeostasis and Induces Angiogenesis in Tumors

(2008) Bryan R. Downie et al.   JOURNAL OF BIOLOGICAL CHEMISTRY